Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3 Mln
P/E Ratio
--
P/B Ratio
2.09
Industry P/E
--
Debt to Equity
--
ROE
-5.4 %
ROCE
-539.57 %
Div. Yield
0 %
Book Value
1.59
EPS
-9.57
CFO
$-60.77 Mln
EBITDA
$-84.17 Mln
Net Profit
$-127.43 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Enveric Biosciences (ENVB)
| -75.63 | -10.88 | -69.53 | -90.81 | -81.37 | -78.50 | -66.13 |
|
BSE Sensex
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Enveric Biosciences (ENVB)
| -72.14 | -37.50 | -95.53 | -78.17 | -52.88 | -48.17 | -94.29 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 38.87 | 10,593.45 | 21.84 | 23.13 | |
| 305.00 | 8,570.17 | 22.78 | 66.44 | |
| 28.07 | 10,589.59 | -- | -28.77 | |
| 107.01 | 10,559.67 | 32.44 | 14.16 |
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of... psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company is headquartered in Naples, Florida. Address: 4851 Tamiami Trail N, Naples, FL, United States, 34103 Read more
CEO & Director
Dr. Joseph Edward Tucker Ph.D.
CEO & Director
Dr. Joseph Edward Tucker Ph.D.
Headquarters
Naples, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Enveric Biosciences Inc (ENVB) stood at $ 3 Mln as on 31-Dec-24
The share price of Enveric Biosciences Inc (ENVB) is $1.31 (NASDAQ) as of 30-Apr-2025 13:37 EDT. Enveric Biosciences Inc (ENVB) has given a return of -81.37% in the last 3 years.
Enveric Biosciences Inc (ENVB) has a market capitalisation of $ 3 Mln as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Enveric Biosciences Inc (ENVB) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Enveric Biosciences Inc (ENVB) and enter the required number of quantities and click on buy to purchase the shares of Enveric Biosciences Inc (ENVB).
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company is headquartered in Naples, Florida. Address: 4851 Tamiami Trail N, Naples, FL, United States, 34103
The CEO & director of Dr. Joseph Edward Tucker Ph.D.. is Enveric Biosciences Inc (ENVB), and CFO & Sr. VP is Dr. Joseph Edward Tucker Ph.D..
There is no promoter pledging in Enveric Biosciences Inc (ENVB).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,014
|
|
|
1,003
|
|
|
956
|
|
|
867
|
| Enveric Biosciences Inc. (ENVB) | Ratios |
|---|---|
|
Return on equity(%)
|
-539.57
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Enveric Biosciences Inc (ENVB) was $0 Mln.
$-0.05
(
